Malignant Intestinal Neoplasm — Trials

Malignant Intestinal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

7,775 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,667
Recruiting: 939
Ph III recruiting: 108
Growth YoY: +12.8%
Industry share: 21%
Top sponsor: Fudan University
Termination share: 25.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (773)

clinicaltrialsPublishedShowing 401–450 of 2,398 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07033026	An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.	recruiting	Phase 2	136	NGM Biopharmaceuticals, IncINDUSTRY	4	Apr 1, 2026	clinicaltrials
NCT07505472	Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Without Concurrent Surufatinib in Neoadjuvant Therapy for Mid-to-low Localized Rectal Cancer of High-risk Criteria(STARS-RC10)	recruiting	Phase 2 / Phase 3	212	The First Hospital of Jilin University